Pharming (PHAR) Change in Account Payables (2020 - 2022)
Historic Change in Account Payables for Pharming (PHAR) over the last 3 years, with Q4 2022 value amounting to -$1.6 million.
- Pharming's Change in Account Payables rose 5893.66% to -$1.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$3.0 million, marking a year-over-year increase of 6798.63%. This contributed to the annual value of -$4.0 million for FY2021, which is 15707.37% down from last year.
- According to the latest figures from Q4 2022, Pharming's Change in Account Payables is -$1.6 million, which was up 5893.66% from $4.2 million recorded in Q2 2022.
- In the past 5 years, Pharming's Change in Account Payables ranged from a high of $4.2 million in Q2 2022 and a low of -$8.9 million during Q3 2020
- For the 3-year period, Pharming's Change in Account Payables averaged around -$1.9 million, with its median value being -$1.6 million (2022).
- Its Change in Account Payables has fluctuated over the past 5 years, first crashed by 5479512.25% in 2021, then skyrocketed by 19370.39% in 2022.
- Over the past 3 years, Pharming's Change in Account Payables (Quarter) stood at $7324.2 in 2020, then tumbled by 54795.12% to -$4.0 million in 2021, then soared by 58.94% to -$1.6 million in 2022.
- Its last three reported values are -$1.6 million in Q4 2022, $4.2 million for Q2 2022, and -$1.6 million during Q1 2022.